相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。PI(3) kinase is associated with a mechanism of immunoresistance in breast and prostate cancer
C. A. Crane et al.
ONCOGENE (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
PD-1 and its ligands in tolerance and immunity
Mary E. Keir et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells
Takeshi Azuma et al.
BLOOD (2008)
Low absolute lymphocyte count is a poor prognostic marker in patients with diffuse large B-cell lymphoma and suggests patients' survival benefit from rituximab
Yasuhiro Oki et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2008)
Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas
A. L. Feldman et al.
LEUKEMIA (2008)
Stromal Gene Signatures in Large-B-Cell Lymphomas
G. Lenz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+ regulatory T cells
Li Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1)
Michal Marzec et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Blocking of monocyte-associated B7-H1 (CD274) enhances HCV-specific T cell immunity in chronic hepatitis C infection
Hye-Young Jeong et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with stage and survival
L. M. Gjerdrum et al.
LEUKEMIA (2007)
The oncoprotein NPM-ALK of anaplastic large-cell lymphoma induces JUNB transcription via ERK1/2 and JunB translation via mTOR signaling
Philipp B. Staber et al.
BLOOD (2007)
CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intraturnoral CD4+CD25- T cells
Zhi-Zhang Yang et al.
BLOOD (2007)
Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway
M. Marzec et al.
ONCOGENE (2007)
Interaction between B7-H1 and PD-1 determines initiation and reversal of T-cell anergy
Fumihiko Tsushima et al.
BLOOD (2007)
Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor based antitumor vaccine
Paola Filipazzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Absolute lymphocyte count predicts therapeutic efficacy of rituximab therapy in follicular lymphomas
Deepti Behl et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma
Andrew T. Parsa et al.
NATURE MEDICINE (2007)
The new B7s: Playing a pivotal role in tumor immunity
Dallas B. Flies et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Bevacizumab: An angiogenesis inhibitor for the treatment of solid malignancies
Ted Shih et al.
CLINICAL THERAPEUTICS (2006)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Absolute lymphocyte count predicts overall survival in follicular lymphomas
Mustaqeem Siddiqui et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Reviving exhausted T lymphocytes during chronic virus infection by B7-H1 blockade
Sheng Yao et al.
TRENDS IN MOLECULAR MEDICINE (2006)
Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma
ZZ Yang et al.
BLOOD (2006)
Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up
RH Thompson et al.
CANCER RESEARCH (2006)
Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation
AL Taylor et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2005)
Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells
CL Berger et al.
BLOOD (2005)
Cancer immunotherapy: moving beyond current vaccines
SA Rosenberg et al.
NATURE MEDICINE (2004)
Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells
SS Dave et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3
WJ Chen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Sensitive and viable identification of antigen-specific CD8+T cells by a flow cytometric assay for degranulation
MR Betts et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2003)
B7-H1 pathway and its role in the evasion of tumor immunity
HD Dong et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2003)
Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity
TJ Curiel et al.
NATURE MEDICINE (2003)
Blockade of programmed death-1 Ligands on dendritic cells enhances T cell activation and cytokine production
JA Brown et al.
JOURNAL OF IMMUNOLOGY (2003)
Profound loss of T-cell receptor repertoire complexity in cutaneous T-cell lymphoma
N Yawalkar et al.
BLOOD (2003)
Role of interleukin-10 in the intracellular sequestration of human leukocyte antigen-DR in monocytes during septic shock
T Fumeaux et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Human leukocyte antigen-DR expression on peripheral monocytes as a predictive marker of sepsis during acute pancreatitis
A Satoh et al.
PANCREAS (2002)
Variable CD7 expression on T cells in the leukemic phase of cutaneous T cell lymphoma (Sezary syndrome)
EC Vonderheid et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2001)
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation
GJ Freeman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)